Fermenta Biotech to raise funds after production boost

Fermenta Biotech Limited's board of directors, in a meeting on December 10, 2025, approved a proposal to raise funds not exceeding INR 150 Crores. The company may issue various securities, including equity shares, convertibles, warrants, or preference shares, through methods such as public issue, rights issue, preferential allotment, or private placement (including QIP). This is subject to shareholder and regulatory approvals.

In a separate announcement on the same date, Fermenta Biotech also stated that its officials would participate in a physical one-to-one investor meeting in Mumbai on December 15, 2025. This interaction will focus on discussing the unaudited financial results for the half year ended September 30, 2025, and the related Investor Presentation, which are publicly available.

The company confirmed that no unpublished price sensitive information (UPSI) is intended to be discussed during these investor interactions. The board meeting, which addressed the fund-raising proposal, commenced at 11:30 a.m. IST and concluded at 2:50 p.m. IST.